Composition for inhibiting expression of advanced glycosylation end product and inhibiting angiosclerosis and preparation method thereof

A technology of composition and extract, applied in the direction of drug combination, cardiovascular system diseases, pharmaceutical formula, etc.

Active Publication Date: 2021-06-01
GUANGZHOU SAIJIAN BIO TECH
View PDF6 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

In recent years, many health food companies have gradually researched and discussed this field, and developed products that

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Composition for inhibiting expression of advanced glycosylation end product and inhibiting angiosclerosis and preparation method thereof
  • Composition for inhibiting expression of advanced glycosylation end product and inhibiting angiosclerosis and preparation method thereof
  • Composition for inhibiting expression of advanced glycosylation end product and inhibiting angiosclerosis and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0039] raw material:

[0040] 10 parts of red grape concentrated powder, 25 parts of turmeric, 20 parts of Haematococcus pluvialis astaxanthin microencapsulated powder and 20 parts of emblica powder.

[0041] Preparation method: Add each component according to the formula amount into a three-dimensional mixer and mix for 30 minutes to obtain a loose powder.

Embodiment 2

[0043] raw material:

[0044] 15 parts of red grape concentrated powder, 15 parts of turmeric, 18 parts of Haematococcus pluvialis astaxanthin microencapsulated powder and 18 parts of emblica powder.

[0045] Method: Put each component into a three-dimensional mixer according to the formula and mix for 30 minutes to obtain loose powder.

Embodiment 3

[0047] raw material:

[0048] 20 parts of concentrated red grape powder, 20 parts of turmeric, 7 parts of Haematococcus pluvialis astaxanthin microencapsulated powder and 7 parts of emblica powder.

[0049] Method: Put each component into a three-dimensional mixer according to the formula and mix for 30 minutes to obtain loose powder.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to the technical field of health care products, in particular to a composition for inhibiting expression of advanced glycosylation end products and inhibiting angiosclerosis and a preparation method of the composition. The composition is prepared from the following raw materials in parts by weight: 2 to 20 parts of red grape concentrated powder, 3 to 30 parts of rhizoma curcumae longae, 1 to 20 parts of haematococcus pluvialis astaxanthin microcapsule powder and 1 to 20 parts of emblic leafflower fruit powder. The raw materials can also comprise 3-30 parts of an elderberry extract, 5-50 parts of a blackberry extract and 4-40 parts of a blackcurrant extract. The preparation method is simple and can be used for preparation according to a conventional process. All the components in the composition have a synergistic effect, and the excellent anti-saccharification and blood vessel softening effects are achieved.

Description

technical field [0001] The invention relates to the technical field of health care products, in particular to a composition for inhibiting the expression of advanced glycation end products and arteriosclerosis and a preparation method thereof. Background technique [0002] Advanced glycation end products (AGEs) are formed by non-enzymatic glycosylation of carbonyl groups (aldehyde groups or ketone groups) of reducing sugars such as glucose and free amino terminals of proteins and lipids. The source of AGEs is divided into two types: exogenous and endogenous. The exogenous source mainly comes from foods rich in carbohydrates and fats. Smoking is also an exogenous source of AGEs; the endogenous source is mainly aldehydes of reducing sugars in the body. The reversible Schiff base is formed through the affinity addition reaction between the group or the keto group and the reducing amino group at the end of the protein under the condition of no enzyme. This process is highly reve...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K36/9066A61P43/00A61P9/10A23L33/10A23L33/105A61K31/122
CPCA61K36/87A61K36/9066A61K36/47A61K36/05A61K31/122A61K36/35A61K36/73A61K36/185A61P43/00A61P9/10A23L33/10A23L33/105A23V2002/00A61K2300/00A23V2200/30A23V2200/326A23V2250/21A23V2250/2112A23V2250/202A23V2250/264A23V2250/6402A23V2250/032A23V2250/5086A23V2250/6418A23V2250/6412A23V2250/6416A23V2250/1628
Inventor 赵小艳陆少敏张美婷孙国满黄生权王祝彬李亚滁
Owner GUANGZHOU SAIJIAN BIO TECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap